CDKN2B and neoplasm: TGFβ1 suppressed tumor development by regulating the cell cycle, via increasing levels of cyclin-dependent kinase inhibitors (e.g., p15InK4b and p21Waf1/Cip1) and reducing c-Myc (Seoane and Gomis, 2017).